These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 355038

  • 1. A clinical trial of cell-wall skeleton of BCG in chemoimmunotherapy of acute leukemia.
    Ohino R, Ueda R, Imai Kato Y, Watanabe E, Morishima Y, Yokomaku S, Kobayashi M, Takeyama H, Ezaki K, Kawashima K, Hirano M, Ohara K, Kosaki T, Yoshikawa S, Yamada K.
    Gan; 1978 Apr; 69(2):179-86. PubMed ID: 355038
    [Abstract] [Full Text] [Related]

  • 2. Chemoimmunotherapy of acute myelogenous leukemia with BCG-cell wall skeleton (CWS).
    Araki K, Kawano H, Kishimoto S.
    Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1171-7. PubMed ID: 286492
    [No Abstract] [Full Text] [Related]

  • 3. Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia.
    Alsabti EA, Taleb AM, Raji HM, Kalil OZ, Saleh KA.
    Jpn J Exp Med; 1979 Jun; 49(3):157-68. PubMed ID: 385948
    [Abstract] [Full Text] [Related]

  • 4. [Results of immunotherapy of acute leukemias with BCG vaccine of Polish production].
    Kardaszewicz E, Japa J.
    Acta Haematol Pol; 1975 Jun; 6(2):149-55. PubMed ID: 1057344
    [Abstract] [Full Text] [Related]

  • 5. Chemoimmunotherapy for acute nonlymphocytic leukemia with BCG-and/or Nocardia rubra-cell wall skeleton (CWS). I. Clinical efficacy.
    Araki K, Kawano F, Matsuzaki H, Uekihara S, Kishimoto S.
    Kumamoto Med J; 1983 Mar; 36(1):15-27. PubMed ID: 6632770
    [No Abstract] [Full Text] [Related]

  • 6. Chemoimmunotherapy for acute nonlymphocytic leukemia with BCG- and/or Nocardia rubra-cell wall skeleton (CWS). II. Analysis of the mechanisms of immunological destruction of the tumor cells.
    Kawano F, Araki K, Eto T, Yoshikawa N, Matsuzaki H, Kishimoto S.
    Kumamoto Med J; 1983 Mar; 36(1):29-38. PubMed ID: 6632771
    [No Abstract] [Full Text] [Related]

  • 7. [Administration of BCG-CWS for the treatment of leukemia in children.--Management of acute leukemia after cessation of maintenance chemotherapy-- (author's transl)].
    Ha K, Tawa A, Shu K, Ikeda T, Yabuuchi H, Nishida M.
    Rinsho Ketsueki; 1980 Jun; 21(6):759-67. PubMed ID: 6936563
    [No Abstract] [Full Text] [Related]

  • 8. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
    Yamamura Y, Yoshizaki K, Azuma I, Yagura T, Watanabe T.
    Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
    [Abstract] [Full Text] [Related]

  • 9. BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.
    Miale TD, Yocum D, Yocum C.
    Biomedicine; 1978 May; 28(2):96-104. PubMed ID: 276382
    [Abstract] [Full Text] [Related]

  • 10. Immunotherapy in acute leukemias. Possible applications in children.
    Mahoney DH, Starling KA.
    Am J Pediatr Hematol Oncol; 1981 May; 3(4):410-8. PubMed ID: 7036781
    [Abstract] [Full Text] [Related]

  • 11. Results of treatment of acute leukaemias with BCG vaccine.
    Kardaszewicz E, Japa J.
    J Hyg Epidemiol Microbiol Immunol; 1976 May; 20(1):20-4. PubMed ID: 1063220
    [No Abstract] [Full Text] [Related]

  • 12. Chemoimmunotherapy of acute leukemia in children.
    Bergolz VM, Kisljak NS, Eremeev VS, Rumjanzev AG, Akimova GV, Molochkina AM, Osipov SG.
    Neoplasma; 1978 May; 25(3):359-63. PubMed ID: 277786
    [Abstract] [Full Text] [Related]

  • 13. Intermittent chemotherapy and immunotherapy with BCG in remission maintenance of children with acute lymphocytic leukemia: effects upon immunological function.
    Ekert H, Jose DG, Wilson FC, Matthews RN, Lay H.
    Int J Cancer; 1975 Jul 15; 16(1):103-12. PubMed ID: 1058172
    [Abstract] [Full Text] [Related]

  • 14. Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy.
    Nishikawa H, Yasaki S, Yoshimoto T, Sakatani M, Itoh M, Masuno T, Namba M, Ogura T, Hirao F, Azuma I, Yamamura Y.
    Gan; 1978 Dec 15; 69(6):819-24. PubMed ID: 750274
    [Abstract] [Full Text] [Related]

  • 15. [Results of 10 years of experiments with immunotherapy of acute leukemia with Polish BCG vaccine].
    Kardaszewicz E, Japa J.
    Pol Arch Med Wewn; 1980 Jan 15; 63(1):39-44. PubMed ID: 6928602
    [No Abstract] [Full Text] [Related]

  • 16. Modifying the biological response to acute myeloid leukemia I. BCG, allogeneic leukemic cells and spontaneous cytotoxicity.
    Arends-Merino A, Sjögren AM, Reizenstein P.
    Anticancer Res; 1983 Jan 15; 3(4):239-41. PubMed ID: 6576728
    [Abstract] [Full Text] [Related]

  • 17. BCG and cancer.
    Bast RC, Zbar B, Borsos T, Rapp HJ.
    N Engl J Med; 1974 Jun 27; 290(26):1458-69. PubMed ID: 4598691
    [No Abstract] [Full Text] [Related]

  • 18. [Our experience in using chemo- and immunotherapy for children with acute leukemia].
    Blau HI, Schultz M.
    Probl Gematol Pereliv Krovi; 1981 Aug 27; 26(8):25-6. PubMed ID: 6946412
    [No Abstract] [Full Text] [Related]

  • 19. [Immunological control over the action of BCG vaccine in the chemoimmunotherapy of acute leukemia in children].
    Kisliak NS, Averbakh MM, Bergolts VM, Moroz AM, Eremeev VS.
    Sov Med; 1978 Nov 27; (11):35-8. PubMed ID: 364684
    [No Abstract] [Full Text] [Related]

  • 20. Long-term remission in acute lymphoid leukemia patients on maintenance chemoimmunotherapy.
    Eremeev VS, Rumyantsev AG, Akimova GV, Osipov SG, Kislyak NS, Bergolz VM.
    Neoplasma; 1981 Nov 27; 28(2):219-21. PubMed ID: 6942239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.